Correlation between salivary IL-10 and clinical features in patients with periodontitis
Keywords:
Interleukin-10, periodontitis, PPD, CAL, BOP,, PI, GIAbstract
Introduction: Periodontitis is an inflammatory condition that leads to the destruction of the tooth-supporting tissues. Its pathogenesis is driven by imbalance in cytokines. Interleukin-10 (IL-10), an anti-inflammatory cytokine, may regulate periodontal inflammation by antagonizing proinflammatory mediators. However, the precise correlation of this polymorphism with disease severity and clinical profiles is unknown.
Objectives: The present study sought to determine the salivary levels of IL-10 in periodontitis patients and healthy controls, and investigate the possible associations between IL-10 concentrations and major clinical periodontal parameters: PPD (Probing Pocket Depth), CAL (Clinical Attachment Loss), BOP (Bleeding on Probing), PI (Plaque Index) and GI (Gingival Index).
Methods: A case-control study tested at Al-Najaf Center for Dentistry clinics from April 2024 to February 2025 on (65) diagnosed periodontitis cases and (45) healthy controls matched with age and gender. Unstimulated whole saliva was collected in the morning under standardized conditions and tested for IL-10 with a commercial enzyme-linked immunosorbent assay (ELISA) kit. Clinical periodontal data were also collected and severity-classified. The statistical analyses were conducted using SPSS version 25 and t–test, ANOVA, and the Pearson’s correlation tested for group differences and associations between IL-10 levels with clinical symptoms. Results: The mean salivary IL-10 level in patients with periodontitis was significantly higher (42.35 ± 11.68 pg/mL) than that of controls (35.27 ± 9.84 pg/mL) (p = 0.023). Levels of IL-10 were significantly correlated with the severity of PPD and CAL (F = 3.71, p = 0.03; F = 7.89, p = 0.001; respectively). Correlation analysis showed moderate to strong positive correlations of IL-10 with PPD (r = 0.45, p 0.02).
Conclusion: High salivary IL-10 levels are related to periodontitis and reflect positively with parameters of tissue destruction, especially PPD and CAL. These results imply that, as a marker of disease severity, IL-10 could be a non-invasive useful biomarker for the progression of periodontal diseases.
References
Tonetti MS, Jepsen S, Jin L, Otomo-Corgel J. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing: A call for global action. J Clin Periodontol. 2017;44(Suppl 18):S1–S11.
Pan W, Yu Q, Wang G, Chen Q. The cytokine network involved in the host immune response in periodontitis. Int J Oral Sci. 2019;11(3):30. doi:10.1038/s41368-019-0064-z
Neurath MF. Cytokines in gingivitis and periodontitis: from pathogenesis to therapy. Front Immunol. 2024;15:1435054.
Relvas M, Mendes-Frias A, Gonçalves M, Salazar F, Lَpez-Jarana P, Silvestre R, Viana da Costa A. Salivary IL-1β, IL-6 and IL-10 Are Key Biomarkers of Periodontitis Severity. Int J Mol Sci. 2024;25(15):8401. doi:10.3390/ijms25158401
Sun L, Wang C, Zhang H, Girnary M, Jiao Y, Zeng E, et al. IL-10 dampens an IL-17–mediated periodontitis trait and protects from excessive inflammation in experimental models. J Clin Invest. 2020;130(3):1283–1296. (DOI not found in search; verify on JCI)
Kim J-Y, Kim H-N. Changes in inflammatory cytokines in saliva after non-surgical periodontal therapy: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18(1):194.
Mohammed MA, Abbas RF, Akram HM. Salivary IL-17 and IL-10 as potential diagnostic biomarkers of different stages of periodontitis in smoker and nonsmoker patients. Eur J Dent. 2023;18:253–264. doi:10.1055/s-0043-1768154
Saremi L, Shafizadeh M, Ghaffari ME, Alipour M, Kiani S. Evaluation of interleukin-10, interleukin-1β, and tumor necrosis factor-α gene polymorphisms in patients with periodontitis and healthy controls. Egypt J Med Hum Genet. 2022;23:157. doi:10.1186/s43042-022-0037.
Bostanci N, Belibasakis GN. Biomarkers in saliva for periodontitis and peri-implantitis. Periodontol 2000. 2018;78(1):164–180.
Zhang Y, He J, He B, Huang R. Salivary biomarkers for periodontitis detection and monitoring: A systematic review. Front Cell Infect Microbiol. 2021;11:781253.
Arias-Bolzmann L, Herrera D, [other authors]. Salivary cytokines as diagnostic markers for periodontitis: a systematic review and meta-analysis. J Periodontol. 2022;93(4):526–540.
Chen J, Yu C, Li M, [other authors]. Salivary cytokine profile in patients with chronic periodontitis. Cytokine. 2020;135:155228.
Teles, R. P., Likhari, V., Socransky, S. S., & Haffajee, A. D. (2009). Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study. Journal of periodontal research, 44(3), 411–417. https://doi.org/10.1111/j.1600-0765.2008.01119.x.
Leira Y, Martيn-Lancharro P, Blanco J, [other authors]. Salivary interleukin-10 in periodontal health and disease: a clinical correlation study. Clin Oral Investig. 2023;27:431–440.
Al-Fahham AA. Development of New LSD Formula when Unequal Observations Numbers of Observations Are. Open Journal of Statistics. 2018;8:258–263. doi:10.4236/ojs.2018.82016
Kozak M, Dabrowska-Zamojcin E, Mazurek-Mochol M, Pawlik A. Cytokines and Their Genetic Polymorphisms Related to Periodontal Disease. Journal of Clinical Medicine. 2020; 9(12):4045. https://doi.org/10.3390/jcm9124045.
Pan W, Yu Q, Wang G, Chen Q. The cytokine network involved in the host immune response in periodontitis. Int J Oral Sci. 2019;11(3):30. doi:10.1038/s41368-019-0064-z
Neurath MF. Cytokines in gingivitis and periodontitis: from pathogenesis to therapy. Front Immunol. 2024;15:1435054.
Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000. 2016;70(1):51–67.
Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta. 2017;1863(10):2482–2492.
Jumaa Abd-Alkareem , S, Luaiby Atrooz , A, Dhia Hasan N. Interleukin 10 Gene Promoter Polymorphisms in Patients with Chronic Periodontitis. Diyala Journal of Medicine [Internet]. 2022 Oct. 15 ;23(1):33-4. Available from: https://djm.uodiyala.edu.iq/index.php/djm/article/view/923
